A 51-year-old with type 2 diabetes and CKD (eGFR 32 mL/min/1.73 m²; UACR 420 mg/g) is on metformin and ACE inhibitor. Which additional therapy has kid...

Question

A 51-year-old with type 2 diabetes and CKD (eGFR 32 mL/min/1.73 m²; UACR 420 mg/g) is on metformin and ACE inhibitor. Which additional therapy has kidney and cardiovascular benefit and should be started?

Accepted Answer

Empagliflozin

Answer

Pioglitazone

Answer

Sitagliptin

Answer

Glyburide

Answer

Acarbose

us-abim MCQ (SBA): Diabetic Kidney Disease

A 51-year-old with type 2 diabetes and CKD (eGFR 32 mL/min/1.73 m²; UACR 420 mg/g) is on metformin and ACE inhibitor. Which additional therapy has kidney and cardiovascular benefit and should be started?